Clinical Trial Update: Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo Vulgaris [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating topical pimecrolimus for vitiligo vulgaris has completed, reporting efficacy and safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo Vulgaris

Drugs mentioned

• Pimecrolimus (pimecrolimus)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Vitiligo Vulgaris | Phase 2 | Status: COMPLETED